Funding, News and Announcements

CIHR is announcing Phase II of the Joint Canada-Israel Health Research Program.

Phase II is directed toward proposals at the intersection between non-communicable chronic disease (NCD) and infectious diseases while strengthening capacity in Canada, Israel and in low and middle income countries (LMIC).

The Program will support teams co-led by three principal investigators: one from Canada, one from Israel and one from an LMIC; with the intention of strengthening scientific capacity, promoting collaboration, equitable partnerships and scientific excellence in all its diversity.

Total funding available: up to CAD 1,460,829 per team over 4 years (up to CAD 500,000 for the PI from Canada, up to CAD 500,000 for the PI from the LMIC and up to CAD 460,829 for the PI from Israel).

Canadian, Israeli, and LMIC investigators co-leading a team are not eligible to hold a grant under this competition if they hold an active grant from Phase I of the JCIHRP at the funding start date for this funding opportunity.

Applicants must register by March 2, 2022.

For more information, you can access the full call, here.

If interested in this opportunity, contact ird@dal.ca.

Deadlines

Internal: March 21, 2022 at 4:30pm. Click here for guidance on internal deadlines and submission processes.

Funder: April 4, 2022 at 1pm Jerusalem time (7am AST). Contact support-soutien@cihr-irsc.gc.ca